Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Opportunities and Forecast to 2030
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term 'consumption' came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
According to APO Research, The global Tuberculosis (TB) Diagnostics market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Diagnostics.
The Tuberculosis (TB) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Tuberculosis (TB) Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Chapter 12: Concluding Insights of the report
According to APO Research, The global Tuberculosis (TB) Diagnostics market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.
APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Diagnostics.
The Tuberculosis (TB) Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Danaher
- Roche
- Thermo Fisher Scientific
- BD
- Abbott
- Hologic
- Qiagen
- BioMerieux
- Hain Lifescience
- Oxford Immunotec
- Culture-Based Diagnostics
- Sputum Smear Microscopy
- Rapid Molecular Diagnostics
- Others
- Diagnostic Laboratories
- Hospitals
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Tuberculosis (TB) Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Tuberculosis (TB) Diagnostics Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Tuberculosis (TB) Diagnostics Market Size by Region (2019-2030)
1.4.1 Global Tuberculosis (TB) Diagnostics Market Size by Region (2019-2024)
1.4.2 Global Tuberculosis (TB) Diagnostics Market Size by Region (2025-2030)
1.5 Key Regions Tuberculosis (TB) Diagnostics Market Size (2019-2030)
1.5.1 North America Tuberculosis (TB) Diagnostics Market Size Growth Rate (2019-2030)
1.5.2 Europe Tuberculosis (TB) Diagnostics Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Growth Rate (2019-2030)
1.5.4 Latin America Tuberculosis (TB) Diagnostics Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth Rate (2019-2030)
2 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Culture-Based Diagnostics
2.1.2 Sputum Smear Microscopy
2.1.3 Rapid Molecular Diagnostics
2.1.4 Others
2.2 Global Tuberculosis (TB) Diagnostics Market Size by Type
2.2.1 Global Tuberculosis (TB) Diagnostics Market Size Overview by Type (2019-2030)
2.2.2 Global Tuberculosis (TB) Diagnostics Historic Market Size Review by Type (2019-2024)
2.2.3 Global Tuberculosis (TB) Diagnostics Market Size Forecasted by Type (2025-2030)
2.3 Global Tuberculosis (TB) Diagnostics Market Size by Regions
2.3.1 North America Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2019-2024)
3 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Diagnostic Laboratories
3.1.2 Hospitals
3.2 Global Tuberculosis (TB) Diagnostics Market Size by Application
3.2.1 Global Tuberculosis (TB) Diagnostics Market Size Overview by Application (2019-2030)
3.2.2 Global Tuberculosis (TB) Diagnostics Historic Market Size Review by Application (2019-2024)
3.2.3 Global Tuberculosis (TB) Diagnostics Market Size Forecasted by Application (2025-2030)
3.3 Global Tuberculosis (TB) Diagnostics Market Size by Regions
3.3.1 North America Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Tuberculosis (TB) Diagnostics Industry Trends
4.2 Tuberculosis (TB) Diagnostics Industry Drivers
4.3 Tuberculosis (TB) Diagnostics Industry Opportunities and Challenges
4.4 Tuberculosis (TB) Diagnostics Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Tuberculosis (TB) Diagnostics Revenue (2019-2024)
5.2 Global Tuberculosis (TB) Diagnostics Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Tuberculosis (TB) Diagnostics Key Company Headquarters & Area Served
5.4 Global Tuberculosis (TB) Diagnostics Company, Product Type & Application
5.5 Global Tuberculosis (TB) Diagnostics Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Tuberculosis (TB) Diagnostics Market CR5 and HHI
5.6.2 Global Top 5 and 10 Tuberculosis (TB) Diagnostics Players Market Share by Revenue in 2023
5.6.3 2023 Tuberculosis (TB) Diagnostics Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Danaher
6.1.1 Danaher Comapny Information
6.1.2 Danaher Business Overview
6.1.3 Danaher Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
6.1.5 Danaher Recent Developments
6.2 Roche
6.2.1 Roche Comapny Information
6.2.2 Roche Business Overview
6.2.3 Roche Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Roche Tuberculosis (TB) Diagnostics Product Portfolio
6.2.5 Roche Recent Developments
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Comapny Information
6.3.2 Thermo Fisher Scientific Business Overview
6.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments
6.4 BD
6.4.1 BD Comapny Information
6.4.2 BD Business Overview
6.4.3 BD Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 BD Tuberculosis (TB) Diagnostics Product Portfolio
6.4.5 BD Recent Developments
6.5 Abbott
6.5.1 Abbott Comapny Information
6.5.2 Abbott Business Overview
6.5.3 Abbott Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
6.5.5 Abbott Recent Developments
6.6 Hologic
6.6.1 Hologic Comapny Information
6.6.2 Hologic Business Overview
6.6.3 Hologic Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
6.6.5 Hologic Recent Developments
6.7 Qiagen
6.7.1 Qiagen Comapny Information
6.7.2 Qiagen Business Overview
6.7.3 Qiagen Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
6.7.5 Qiagen Recent Developments
6.8 BioMerieux
6.8.1 BioMerieux Comapny Information
6.8.2 BioMerieux Business Overview
6.8.3 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
6.8.5 BioMerieux Recent Developments
6.9 Hain Lifescience
6.9.1 Hain Lifescience Comapny Information
6.9.2 Hain Lifescience Business Overview
6.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
6.9.5 Hain Lifescience Recent Developments
6.10 Oxford Immunotec
6.10.1 Oxford Immunotec Comapny Information
6.10.2 Oxford Immunotec Business Overview
6.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
6.10.5 Oxford Immunotec Recent Developments
7 NORTH AMERICA
7.1 North America Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
7.3 North America Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
8.3 Europe Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
9.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
10.3 Latin America Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
11.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Tuberculosis (TB) Diagnostics Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Tuberculosis (TB) Diagnostics Market Size by Region (2019-2030)
1.4.1 Global Tuberculosis (TB) Diagnostics Market Size by Region (2019-2024)
1.4.2 Global Tuberculosis (TB) Diagnostics Market Size by Region (2025-2030)
1.5 Key Regions Tuberculosis (TB) Diagnostics Market Size (2019-2030)
1.5.1 North America Tuberculosis (TB) Diagnostics Market Size Growth Rate (2019-2030)
1.5.2 Europe Tuberculosis (TB) Diagnostics Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Growth Rate (2019-2030)
1.5.4 Latin America Tuberculosis (TB) Diagnostics Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth Rate (2019-2030)
2 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Culture-Based Diagnostics
2.1.2 Sputum Smear Microscopy
2.1.3 Rapid Molecular Diagnostics
2.1.4 Others
2.2 Global Tuberculosis (TB) Diagnostics Market Size by Type
2.2.1 Global Tuberculosis (TB) Diagnostics Market Size Overview by Type (2019-2030)
2.2.2 Global Tuberculosis (TB) Diagnostics Historic Market Size Review by Type (2019-2024)
2.2.3 Global Tuberculosis (TB) Diagnostics Market Size Forecasted by Type (2025-2030)
2.3 Global Tuberculosis (TB) Diagnostics Market Size by Regions
2.3.1 North America Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size Breakdown by Type (2019-2024)
3 TUBERCULOSIS (TB) DIAGNOSTICS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Diagnostic Laboratories
3.1.2 Hospitals
3.2 Global Tuberculosis (TB) Diagnostics Market Size by Application
3.2.1 Global Tuberculosis (TB) Diagnostics Market Size Overview by Application (2019-2030)
3.2.2 Global Tuberculosis (TB) Diagnostics Historic Market Size Review by Application (2019-2024)
3.2.3 Global Tuberculosis (TB) Diagnostics Market Size Forecasted by Application (2025-2030)
3.3 Global Tuberculosis (TB) Diagnostics Market Size by Regions
3.3.1 North America Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Tuberculosis (TB) Diagnostics Industry Trends
4.2 Tuberculosis (TB) Diagnostics Industry Drivers
4.3 Tuberculosis (TB) Diagnostics Industry Opportunities and Challenges
4.4 Tuberculosis (TB) Diagnostics Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Tuberculosis (TB) Diagnostics Revenue (2019-2024)
5.2 Global Tuberculosis (TB) Diagnostics Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Tuberculosis (TB) Diagnostics Key Company Headquarters & Area Served
5.4 Global Tuberculosis (TB) Diagnostics Company, Product Type & Application
5.5 Global Tuberculosis (TB) Diagnostics Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Tuberculosis (TB) Diagnostics Market CR5 and HHI
5.6.2 Global Top 5 and 10 Tuberculosis (TB) Diagnostics Players Market Share by Revenue in 2023
5.6.3 2023 Tuberculosis (TB) Diagnostics Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Danaher
6.1.1 Danaher Comapny Information
6.1.2 Danaher Business Overview
6.1.3 Danaher Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Danaher Tuberculosis (TB) Diagnostics Product Portfolio
6.1.5 Danaher Recent Developments
6.2 Roche
6.2.1 Roche Comapny Information
6.2.2 Roche Business Overview
6.2.3 Roche Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Roche Tuberculosis (TB) Diagnostics Product Portfolio
6.2.5 Roche Recent Developments
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Comapny Information
6.3.2 Thermo Fisher Scientific Business Overview
6.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments
6.4 BD
6.4.1 BD Comapny Information
6.4.2 BD Business Overview
6.4.3 BD Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 BD Tuberculosis (TB) Diagnostics Product Portfolio
6.4.5 BD Recent Developments
6.5 Abbott
6.5.1 Abbott Comapny Information
6.5.2 Abbott Business Overview
6.5.3 Abbott Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Abbott Tuberculosis (TB) Diagnostics Product Portfolio
6.5.5 Abbott Recent Developments
6.6 Hologic
6.6.1 Hologic Comapny Information
6.6.2 Hologic Business Overview
6.6.3 Hologic Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Hologic Tuberculosis (TB) Diagnostics Product Portfolio
6.6.5 Hologic Recent Developments
6.7 Qiagen
6.7.1 Qiagen Comapny Information
6.7.2 Qiagen Business Overview
6.7.3 Qiagen Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Qiagen Tuberculosis (TB) Diagnostics Product Portfolio
6.7.5 Qiagen Recent Developments
6.8 BioMerieux
6.8.1 BioMerieux Comapny Information
6.8.2 BioMerieux Business Overview
6.8.3 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 BioMerieux Tuberculosis (TB) Diagnostics Product Portfolio
6.8.5 BioMerieux Recent Developments
6.9 Hain Lifescience
6.9.1 Hain Lifescience Comapny Information
6.9.2 Hain Lifescience Business Overview
6.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Product Portfolio
6.9.5 Hain Lifescience Recent Developments
6.10 Oxford Immunotec
6.10.1 Oxford Immunotec Comapny Information
6.10.2 Oxford Immunotec Business Overview
6.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Portfolio
6.10.5 Oxford Immunotec Recent Developments
7 NORTH AMERICA
7.1 North America Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
7.3 North America Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
8.3 Europe Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
9.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
10.3 Latin America Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2019-2024)
11.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
